Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
42.45
-0.01 (-0.02%)
At close: Jul 3, 2025, 1:00 PM
42.13
-0.32 (-0.75%)
After-hours: Jul 3, 2025, 2:49 PM EDT
Bruker Market Cap
Bruker has a market cap or net worth of $6.43 billion as of July 3, 2025. Its market cap has decreased by -31.75% in one year.
Market Cap
6.43B
Enterprise Value
8.37B
1-Year Change
-31.75%
Ranking
Category
Stock Price
$42.45
Market Cap Chart
Since August 4, 2000, Bruker's market cap has increased from $1.23B to $6.43B, an increase of 421.40%. That is a compound annual growth rate of 6.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 6.43B | -27.62% |
| Dec 31, 2024 | 8.89B | -12.62% |
| Dec 29, 2023 | 10.17B | 1.17% |
| Dec 30, 2022 | 10.05B | -21.00% |
| Dec 31, 2021 | 12.73B | 53.55% |
| Dec 31, 2020 | 8.29B | 5.59% |
| Dec 31, 2019 | 7.85B | 68.40% |
| Dec 31, 2018 | 4.66B | -12.70% |
| Dec 29, 2017 | 5.34B | 57.15% |
| Dec 30, 2016 | 3.40B | -16.62% |
| Dec 31, 2015 | 4.07B | 23.26% |
| Dec 31, 2014 | 3.31B | -0.21% |
| Dec 31, 2013 | 3.31B | 30.72% |
| Dec 31, 2012 | 2.53B | 23.02% |
| Dec 30, 2011 | 2.06B | -24.73% |
| Dec 31, 2010 | 2.74B | 38.20% |
| Dec 31, 2009 | 1.98B | 198.73% |
| Dec 31, 2008 | 662.80M | -52.76% |
| Dec 31, 2007 | 1.40B | 82.75% |
| Dec 29, 2006 | 767.70M | 76.48% |
| Dec 30, 2005 | 435.00M | 20.63% |
| Dec 31, 2004 | 360.60M | -7.85% |
| Dec 31, 2003 | 391.30M | 46.66% |
| Dec 31, 2002 | 266.80M | -70.26% |
| Dec 31, 2001 | 897.20M | -30.38% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |